Big Moving Stock keep track of the biggest moving stocks in the market.
The Hot Industries
REIT - Retail 2
The Hot Sectors
Consumer Goods 3
JNJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers a range of products used in the baby care, skin care, oral care, wound care, and womens health fields, as well as nutritionals, over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSONS, AVEENO, CLEAN & CLEAR, DABAO, JOHNSONS Adult, LUBRIDERM, NEUTROGENA, RoC, VENDÔME, LISTERINE, BAND-AID, NEOSPORIN, STAYFREE, CAREFREE, o.b. tampon, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, cardiovascular, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, metabolic, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers various products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products to wholesalers, hospitals, and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Johnson & Johnson (JNJ) Stock Rises Today Following Texas Lawsuit Dismissal24 Oct 2014, 8:44 amNEW YORK (TheStreet) -- Johnson & Johnson shares are up 0.3% to $102.94 on Friday after the consumer products manufacturer won a lawsuit brought against it by a Texas woman who sought damages for what she claimed was a faulty metal on metal hip implant that poisoned her. The jury unanimously ruled in favor of Johnson & Johnson finding that the product isn't defective and that the company had ...
17 stock trades in 91 seconds22 Oct 2014, 6:13 pmThe "Fast Money" pros share how they're playing weakness in the stock market.
One Put, One Call Option To Know About for Johnson & Johnson20 Oct 2014, 10:31 amConsistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call contract, from the April 2015 expiration for JNJ.
Why Johnson & Johnson (JNJ) Stock Is Up Today15 Oct 2014, 8:59 amNEW YORK (TheStreet) -- Johnson & Johnson ashares are higher by 0.45% to $97.44 after the company reported third quarter net income of $4.7 billion, or $1.66 per diluted share, compared to $2.9 billion, or $1.04 per diluted share, for the same period a year ago. Third quarterasales were $18.5 billion compared to $17.6 billion for the same quarter in 2013, the company said. J&J, which makes a ...
How Will Johnson & Johnson (JNJ) Stock React Today to Its Third Quarter Earnings Results?14 Oct 2014, 8:58 amNEW YORK (TheStreet) -- Drugs and health products companyaJohnson & Johnsona posted higher than estimated third quarter earnings of $1.50 per share, topping the analysts' estimates of $1.43 per share. The company reported that its third quarter domestic sales rose 11.6% to $8.84 billion, and posted total revenue of $18.5 billion for the quarter which was higher thanathe consensus estimate of $18 ...
Pre-Market Earnings Report for October 14, 2014 : JNJ, WFC, JPM, C, JBHT, DPZ, WWW, DFRG, ACCKF13 Oct 2014, 3:13 pmPre-Market Earnings Report for October 14, 2014 : JNJ, WFC, JPM, C, JBHT, DPZ, WWW, DFRG, ACCKF
Interesting October Stock Options for Johnson & Johnson13 Oct 2014, 10:59 amConsistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call contract, from the October expiration for JNJ.
Why Johnson & Johnson (JNJ) Stock Is Climbing Today10 Oct 2014, 8:00 amNEW YORK (TheStreet) -- Shares of Johnsona& Johnsona are higher by 0.14% to $102.22 in early market tradingaafter analysts ataCredit Suisseaupgraded the consumer health companyato "neutral"afrom "underperform" this morning. The health products giantais currently covered by 22 Wall Street analysts, and has an average price target of $109.23. Johnson & Johnson isaone of the biggest health care ...
Why Johnson & Johnson (JNJ) Stock Is Lower Today1 Oct 2014, 7:44 amNEW YORK (TheStreet) -- Shares of Johnson & Johnsona aare lower by 0.68% to $105.86 in early market trading today after the the healthaproducts company was downgraded to "market perform" from "outperform" at Bernstein this morning. The firm cited the slowing pharmaceutical unit due to increased competition for its cut in its rating. Analysts at Bernstein also said the 2015 estimates for the ...
Johnson & Johnson (JNJ) to Acquire Alios BioPharma30 Sep 2014, 4:43 pmJNJ stock is in focus after the company moves to acquire Alios BioPharma.